U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 369

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr5:138643838
GRCh38:
Chr5:139308149
MATR3K245IAmyotrophic lateral sclerosis type 21Uncertain significancecriteria provided, single submitter
2.
GRCh37:
Chr5:138643462
GRCh38:
Chr5:139307773
MATR3R120GAmyotrophic lateral sclerosis type 21Uncertain significance
(May 30, 2019)
criteria provided, single submitter
3.
GRCh37:
Chr5:138665061
GRCh38:
Chr5:139329372
MATR3R503G, R541G, R551G, R553G, R554G, R841G, R889GAmyotrophic lateral sclerosis type 21Uncertain significance
(Dec 24, 2019)
criteria provided, single submitter
4.
GRCh37:
Chr5:138643105-138665084
MATR3Amyotrophic lateral sclerosis type 21Uncertain significance
(Jan 11, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr5:138658615
GRCh38:
Chr5:139322926
LOC126807526, MATR3D365N, D403N, D415N, D416N, D703NAmyotrophic lateral sclerosis type 21Uncertain significance
(May 25, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr5:138655200
GRCh38:
Chr5:139319511
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Jul 23, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr5:138661179
GRCh38:
Chr5:139325490
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Jul 3, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr5:138658580
GRCh38:
Chr5:139322891
LOC126807526, MATR3G391E, G404E, G691E, G403E, G353EInborn genetic diseases, Amyotrophic lateral sclerosis type 21Uncertain significance
(Jul 19, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr5:138661147
GRCh38:
Chr5:139325458
MATR3L385F, L423F, L436F, L771F, L723F, L433F, L435FAmyotrophic lateral sclerosis type 21Uncertain significance
(Sep 27, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr5:138643190-138643191
GRCh38:
Chr5:139307501-139307502
MATR3Amyotrophic lateral sclerosis type 21Uncertain significance
(Aug 30, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr5:138661361
GRCh38:
Chr5:139325672
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Apr 7, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr5:138652811
GRCh38:
Chr5:139317122
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Aug 27, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr5:138658416
GRCh38:
Chr5:139322727
LOC126807526, MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Dec 24, 2021)
criteria provided, single submitter
14.
GRCh37:
Chr5:138657728
GRCh38:
Chr5:139322039
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Apr 24, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr5:138643853
GRCh38:
Chr5:139308164
MATR3Y250CAmyotrophic lateral sclerosis type 21, Inborn genetic diseasesUncertain significance
(Nov 21, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr5:138665036
GRCh38:
Chr5:139329347
MATR3Amyotrophic lateral sclerosis type 21Uncertain significance
(Oct 23, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr5:138657571-138657574
GRCh38:
Chr5:139321882-139321885
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Sep 23, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr5:138658133
GRCh38:
Chr5:139322444
LOC126807526, MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Aug 9, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr5:138653279
GRCh38:
Chr5:139317590
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Jun 19, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr5:138643801
GRCh38:
Chr5:139308112
MATR3D233NAmyotrophic lateral sclerosis type 21Uncertain significance
(Mar 12, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr5:138658402
GRCh38:
Chr5:139322713
LOC126807526, MATR3G294S, G332S, G344S, G345S, G632SAmyotrophic lateral sclerosis type 21Uncertain significance
(Feb 24, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr5:138643608
GRCh38:
Chr5:139307919
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Jun 15, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr5:138643524
GRCh38:
Chr5:139307835
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Jul 20, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr5:138643122
GRCh38:
Chr5:139307433
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Jun 2, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr5:138653375
GRCh38:
Chr5:139317686
MATR3I137V, I138V, I125V, I425V, I87Vnot provided, Amyotrophic lateral sclerosis type 21Uncertain significance
(Oct 9, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr5:138655199
GRCh38:
Chr5:139319510
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Jun 8, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr5:138661281
GRCh38:
Chr5:139325592
MATR3D480E, D429E, D467E, D479E, D767E, D477E, D815EMATR3-related condition, Amyotrophic lateral sclerosis type 21Uncertain significance
(Feb 14, 2023)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr5:138657725
GRCh38:
Chr5:139322036
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Jan 3, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr5:138657579-138657582
GRCh38:
Chr5:139321890-139321893
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Sep 7, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr5:138643533
GRCh38:
Chr5:139307844
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Jul 20, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr5:138643543
GRCh38:
Chr5:139307854
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Aug 28, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr5:138658568
GRCh38:
Chr5:139322879
LOC126807526, MATR3V399G, V349G, V400G, V687G, V387GAmyotrophic lateral sclerosis type 21Uncertain significance
(May 30, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr5:138665073
GRCh38:
Chr5:139329384
MATR3K507E, K545E, K555E, K557E, K558E, K845E, K893EAmyotrophic lateral sclerosis type 21Uncertain significance
(Jul 13, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr5:138657652
GRCh38:
Chr5:139321963
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Aug 20, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr5:138652777
GRCh38:
Chr5:139317088
MATR3M389V, M51V, M101V, M102V, M89VAmyotrophic lateral sclerosis type 21Uncertain significance
(Mar 6, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr5:138643851
GRCh38:
Chr5:139308162
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Jun 14, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr5:138643269
GRCh38:
Chr5:139307580
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Apr 4, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr5:138657570
GRCh38:
Chr5:139321881
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(May 12, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr5:138650445
GRCh38:
Chr5:139314756
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Apr 30, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr5:138658670
GRCh38:
Chr5:139322981
LOC126807526, MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Jul 7, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr5:138658524
GRCh38:
Chr5:139322835
MATR3, LOC126807526Amyotrophic lateral sclerosis type 21Likely benign
(Dec 16, 2021)
criteria provided, single submitter
42.
GRCh37:
Chr5:138661848
GRCh38:
Chr5:139326159
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Apr 14, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr5:138658307
GRCh38:
Chr5:139322618
LOC126807526, MATR3D300G, D313G, D600G, D262G, D312GAmyotrophic lateral sclerosis type 21Uncertain significance
(May 17, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr5:138661303
GRCh38:
Chr5:139325614
MATR3I823V, I485V, I487V, I488V, I437V, I475V, I775VAmyotrophic lateral sclerosis type 21Uncertain significance
(Oct 22, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr5:138661280
GRCh38:
Chr5:139325591
MATR3D467V, D767V, D429V, D480V, D477V, D479V, D815VAmyotrophic lateral sclerosis type 21Uncertain significance
(Mar 19, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr5:138658456
GRCh38:
Chr5:139322767
LOC126807526, MATR3M350V, M362V, M363V, M650V, M312VAmyotrophic lateral sclerosis type 21Uncertain significance
(Mar 1, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr5:138653348
GRCh38:
Chr5:139317659
MATR3L416I, L78I, L116I, L128I, L129IAmyotrophic lateral sclerosis type 21Uncertain significance
(Jan 21, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr5:138655143
GRCh38:
Chr5:139319454
MATR3P181fs, P232fs, P231fs, P519fs, P219fsAmyotrophic lateral sclerosis type 21Uncertain significance
(Jan 18, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr5:138657700
GRCh38:
Chr5:139322011
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Jan 17, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr5:138643337
GRCh38:
Chr5:139307648
MATR3T78NAmyotrophic lateral sclerosis type 21Uncertain significance
(Mar 28, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr5:138651424
GRCh38:
Chr5:139315735
MATR3T338R, T51R, T38R, T50RAmyotrophic lateral sclerosis type 21Uncertain significance
(Jun 27, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr5:138644024-138644028
GRCh38:
Chr5:139308335-139308339
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Sep 15, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr5:138661353-138661354
GRCh38:
Chr5:139325664-139325665
MATR3Amyotrophic lateral sclerosis type 21Uncertain significance
(Apr 4, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr5:138661170
GRCh38:
Chr5:139325481
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Jul 20, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr5:138643578
GRCh38:
Chr5:139307889
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Dec 28, 2021)
criteria provided, single submitter
56.
GRCh37:
Chr5:138661183
GRCh38:
Chr5:139325494
MATR3I435V, I397V, I448V, I783V, I445V, I447V, I735VAmyotrophic lateral sclerosis type 21Uncertain significance
(Jun 17, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr5:138652727
GRCh38:
Chr5:139317038
MATR3Amyotrophic lateral sclerosis type 21Uncertain significance
(Jun 24, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr5:138657626
GRCh38:
Chr5:139321937
MATR3M261V, M548V, M210V, M248V, M260VAmyotrophic lateral sclerosis type 21Uncertain significance
(Apr 13, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr5:138661857
GRCh38:
Chr5:139326168
MATR3D505N, D455N, D841N, D506N, D793N, D493N, D503NAmyotrophic lateral sclerosis type 21Uncertain significance
(Dec 21, 2021)
criteria provided, single submitter
60.
GRCh37:
Chr5:138658437
GRCh38:
Chr5:139322748
LOC126807526, MATR3Q305H, Q343H, Q356H, Q355H, Q643HAmyotrophic lateral sclerosis type 21Uncertain significance
(Mar 8, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr5:138658369
GRCh38:
Chr5:139322680
LOC126807526, MATR3S283A, S321A, S621A, S333A, S334AAmyotrophic lateral sclerosis type 21Uncertain significance
(Oct 8, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr5:138654632
GRCh38:
Chr5:139318943
MATR3Q160H, Q448H, Q161H, Q110H, Q148HAmyotrophic lateral sclerosis type 21Uncertain significance
(Jan 5, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr5:138661928
GRCh38:
Chr5:139326239
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Aug 24, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr5:138658621
GRCh38:
Chr5:139322932
LOC126807526, MATR3S417C, S367C, S405C, S705C, S418CAmyotrophic lateral sclerosis type 21Uncertain significance
(Oct 5, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr5:138665021-138665024
GRCh38:
Chr5:139329332-139329335
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Jun 24, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr5:138658268
GRCh38:
Chr5:139322579
LOC126807526, MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Oct 6, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr5:138658362
GRCh38:
Chr5:139322673
LOC126807526, MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Oct 15, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr5:138654701
GRCh38:
Chr5:139319012
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Oct 12, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr5:138643566
GRCh38:
Chr5:139307877
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Sep 15, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr5:138665025-138665026
GRCh38:
Chr5:139329336-139329337
MATR3Amyotrophic lateral sclerosis type 21Uncertain significance
(Sep 2, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr5:138657576
GRCh38:
Chr5:139321887
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Sep 1, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr5:138650417
GRCh38:
Chr5:139314728
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Sep 1, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr5:138654686
GRCh38:
Chr5:139318997
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Aug 21, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr5:138643410
GRCh38:
Chr5:139307721
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Aug 6, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr5:138661985
GRCh38:
Chr5:139326296
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Aug 10, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr5:138643257
GRCh38:
Chr5:139307568
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Sep 1, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr5:138643974
GRCh38:
Chr5:139308285
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Jul 3, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr5:138654643
GRCh38:
Chr5:139318954
MATR3D164G, D152G, D165G, D114G, D452GAmyotrophic lateral sclerosis type 21Uncertain significance
(Jun 24, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr5:138643847
GRCh38:
Chr5:139308158
MATR3S248IAmyotrophic lateral sclerosis type 21Uncertain significance
(Jun 22, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr5:138643982
GRCh38:
Chr5:139308293
MATR3C293YAmyotrophic lateral sclerosis type 21Uncertain significance
(Jun 19, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr5:138661167
GRCh38:
Chr5:139325478
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Aug 22, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr5:138661165
GRCh38:
Chr5:139325476
MATR3A429T, A441T, A442T, A777T, A439T, A729T, A391TAmyotrophic lateral sclerosis type 21Uncertain significance
(Jul 24, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr5:138661953
GRCh38:
Chr5:139326264
MATR3P537A, P487A, P525A, P535A, P873A, P538A, P825AAmyotrophic lateral sclerosis type 21Uncertain significance
(Jun 22, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr5:138658386
GRCh38:
Chr5:139322697
LOC126807526, MATR3E338D, E288D, E326D, E339D, E626DAmyotrophic lateral sclerosis type 21Uncertain significance
(Sep 1, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr5:138643563
GRCh38:
Chr5:139307874
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Mar 17, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr5:138651760-138651761
GRCh38:
Chr5:139316071-139316072
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Feb 23, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr5:138654671
GRCh38:
Chr5:139318982
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Mar 20, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr5:138643890
GRCh38:
Chr5:139308201
MATR3E262DAmyotrophic lateral sclerosis type 21Uncertain significance
(Jul 1, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr5:138665079
GRCh38:
Chr5:139329390
MATR3T547A, T559A, T557A, T560A, T509A, T847A, T895AAmyotrophic lateral sclerosis type 21Uncertain significance
(May 6, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr5:138661215
GRCh38:
Chr5:139325526
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Jan 14, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr5:138658435
GRCh38:
Chr5:139322746
LOC126807526, MATR3Q356K, Q643K, Q355K, Q343K, Q305KAmyotrophic lateral sclerosis type 21Uncertain significance
(Sep 9, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr5:138643987
GRCh38:
Chr5:139308298
MATR3I295VAmyotrophic lateral sclerosis type 21Uncertain significance
(May 3, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr5:138651440
GRCh38:
Chr5:139315751
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Apr 26, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr5:138643216
GRCh38:
Chr5:139307527
MATR3M38VAmyotrophic lateral sclerosis type 21Uncertain significance
(Aug 2, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr5:138654587
GRCh38:
Chr5:139318898
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Apr 1, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr5:138653347
GRCh38:
Chr5:139317658
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Jul 6, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr5:138650403
GRCh38:
Chr5:139314714
MATR3Amyotrophic lateral sclerosis type 21Uncertain significance
(Oct 13, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr5:138643197
GRCh38:
Chr5:139307508
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Jul 23, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr5:138654620
GRCh38:
Chr5:139318931
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Jun 21, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr5:138657737
GRCh38:
Chr5:139322048
MATR3Amyotrophic lateral sclerosis type 21Likely benign
(Aug 5, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination